The patient takes their completed request form to any pathology collection centre to get his or her blood taken.
For international customers, please use the files below for sample logistics.
After the patient’s DNA is extracted from the blood sample, we sequence that patient’s exome or whole genome using advanced sequencing technology.
Once sequencing is complete, our team of experts analyse and interpret the resulting genomic information, using an award-winning bioinformatics pipeline*, to identify clinically significant variants.
Our team of highly skilled specialists will review clinically significant variants and generate a report outlining the findings of our analysis. We encrypt and deliver the report to the requesting clinician.
The referring clinician, genetic health professional and patient meet to discuss the results and implications of the test.
We securely store the patient’s genetic data so that it can be reanalysed and reinterpreted in the future. Patients have the opportunity to have their data reanalysed and reinterpreted (upon request from referring clinician**):
for the same indication, if no diagnosis was identified on the initial test;
for new, emerging or unrelated indications;
in the light of new knowledge.